ArticleHeliyon2024

Integrating MR radiomics and dynamic hematological factors predicts pathological response to neoadjuvant chemoradiotherapy in esophageal cancer.

Yunsong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.